08.19.25 -- STREAM Edition: Freezing Studies For Single-Use Solutions: Long-Term

Watch part 2 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about long-term freezing studies.

During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.

Learn about a system that uses a gentle elutriation process to give manufacturers a cleaner cell population to begin cell therapy production processes such as CAR-T.

Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

According to the researchers, this plasma-based measurement has the potential to serve as a critical pharmacodynamic biomarker, facilitating the assessment of novel therapeutic approaches.

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

Explore how a vertical wheel bioreactor enables scalable iPSC expansion and differentiation, from 0.1L to 80L, with robust seed train optimization and consistent cell quality.

In this episode of Cell & Gene: The Podcast, Host Erin Harris dives into the world of retinal gene therapy with Kenji Fujita, M.D., Chief Medical Officer of Atsena Therapeutics.

Discover a scalable, and automated system cell processing platform that reduces cleanroom requirements and enables parallel manufacturing of cellular material on multiple instruments — in one room.